Holen Sie sich die Stockscreener-App
3.25
3.25%
-0.14
Schlusskurs vom Vortag:
$3.39
Offen:
$3.43
24-Stunden-Volumen:
24,647
Relative Volume:
0.14
Marktkapitalisierung:
$10.41M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-37.75M
KGV:
-1.00
EPS:
-3.25
Netto-Cashflow:
$-30.91M
1W Leistung:
-8.64%
1M Leistung:
-43.25%
6M Leistung:
+1,112%
1J Leistung:
+61.57%
1-Tages-Spanne:
$3.25
$3.43
1-Wochen-Bereich:
$3.25
$3.61
52-Wochen-Spanne:
$0.224
$10.19
Cellectar Biosciences Inc Stock (CLRB) Company Profile
Firmenname
Cellectar Biosciences Inc
Sektor
Branche
Telefon
(608) 441-8120
Adresse
100 CAMPUS DRIVE, FLORHAM PARK, NJ
Vergleichen Sie CLRB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLRB
Cellectar Biosciences Inc
|
3.26 | 10.82M | 0 | -37.75M | -30.91M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.67 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
632.59 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.00 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
815.91 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.01 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-05 | Fortgesetzt | Ladenburg Thalmann | Buy |
| 2020-07-01 | Eingeleitet | Oppenheimer | Outperform |
| 2020-01-21 | Fortgesetzt | ROTH Capital | Buy |
| 2019-09-13 | Eingeleitet | ROTH Capital | Buy |
| 2016-12-21 | Eingeleitet | Ladenburg Thalmann | Buy |
Cellectar Biosciences Inc Aktie (CLRB) Neueste Nachrichten
How hedge fund analytics apply to Cellectar Biosciences Inc. stock2025 Key Lessons & Step-by-Step Trade Execution Guides - newser.com
Why Cellectar Biosciences Inc. stock could outperform in 2025July 2025 Snapshot & Free Real-Time Market Sentiment Alerts - newser.com
How strong is Cellectar Biosciences Inc. (NV4) stock earnings growthTrade Risk Report & Low Risk High Reward Ideas - newser.com
Using data tools to time your Cellectar Biosciences Inc. exitJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - newser.com
Using data filters to optimize entry into Cellectar Biosciences Inc.Market Performance Report & AI Powered Market Entry Strategies - newser.com
Will Cellectar Biosciences Inc. benefit from macro trendsWeekly Trade Analysis & High Accuracy Investment Entry Signals - newser.com
Is Morguard Real Estate Investment Trust T0L a good long term investmentBlue Chip Stock Analysis & Free Long-Term Investment Planning - earlytimes.in
Cellectar Biosciences Inc Stock Analysis and ForecastGeopolitical Risk Analysis & Small Capital Growth Tips - earlytimes.in
Why analysts remain bullish on Cellectar Biosciences Inc. stock2025 Investor Takeaways & Weekly Momentum Picks - newser.com
Can Cellectar Biosciences Inc. stock weather global recessionGap Up & Fast Entry Momentum Trade Alerts - newser.com
How Cellectar Biosciences Inc. (NV4) stock correlates with oil marketsM&A Rumor & AI Driven Price Forecasts - newser.com
Will Cellectar Biosciences Inc. stock pay special dividendsEarnings Recap Summary & Daily Profit Maximizing Trade Tips - newser.com
Has Cellectar Biosciences Inc. found a price floor2025 Market WrapUp & Low Drawdown Investment Ideas - newser.com
Using Python tools to backtest Cellectar Biosciences Inc. strategiesQuarterly Earnings Summary & Long-Term Safe Investment Ideas - newser.com
Cellectar Biosciences, Inc. (CLRB) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Published on: 2025-11-01 12:28:59 - newser.com
Published on: 2025-11-01 05:42:39 - newser.com
Is Cellectar Biosciences Inc. (NV4) stock supported by strong fundamentalsAnalyst Downgrade & Stock Portfolio Risk Control - newser.com
Published on: 2025-11-01 03:42:44 - newser.com
Will Cellectar Biosciences Inc. (NV4) stock split increase liquidity2025 Risk Factors & Expert Approved Trade Ideas - newser.com
Will Cellectar Biosciences Inc. stock gain from government policiesQuarterly Portfolio Report & Real-Time Market Sentiment Reports - newser.com
How analysts rate Cellectar Biosciences Inc. stock todayJuly 2025 Institutional & Verified Short-Term Plans - newser.com
Is Cellectar Biosciences Inc. stock a safe investment in uncertain marketsJuly 2025 Drop Watch & Long-Term Safe Return Strategies - newser.com
What the charts say about Cellectar Biosciences Inc. today2025 Volatility Report & Smart Money Movement Alerts - newser.com
Why Cellectar Biosciences Inc. (NV4) stock stays on top picks2025 Volatility Report & Stock Portfolio Risk Control - newser.com
Is Cellectar Biosciences Inc. stock a buy in volatile marketsJuly 2025 PostEarnings & Weekly Breakout Opportunity Watchlist - newser.com
Using RSI to spot recovery in Cellectar Biosciences Inc.Market Rally & AI Enhanced Execution Alerts - newser.com
Can Cellectar Biosciences Inc. hit a new high this monthWeekly Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Cellectar Biosciences Inc NV4 Stock Analysis and ForecastChart Pattern Recognition & Build Winning Strategies With Zero Cost - earlytimes.in
Is Cellectar Biosciences Inc. stock positioned for long term growthMarket Growth Summary & Real-Time Volume Trigger Notifications - newser.com
Is Cellectar Biosciences Inc. stock a bargain at current levels2025 Analyst Calls & Free Community Supported Trade Ideas - newser.com
Finanzdaten der Cellectar Biosciences Inc-Aktie (CLRB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cellectar Biosciences Inc-Aktie (CLRB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Longcor Jarrod | Chief Operating Officer |
Jul 02 '25 |
Buy |
4.99 |
10,000 |
49,900 |
12,768 |
| Kolean Chad J | Chief Financial Officer |
Jul 02 '25 |
Buy |
4.99 |
5,000 |
24,950 |
6,418 |
| Longcor Jarrod | Chief Operating Officer |
Jan 10 '25 |
Buy |
0.28 |
30,000 |
8,400 |
83,141 |
0.66%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):